Unbelievable! A new study reveals a groundbreaking benefit of Mounjaro: the ability to reverse deadly liver disease. Belinda and Gillian, two women who were diagnosed with fibrosis and cirrhosis, are now on the path to recovery. Doctors are astounded by the results.
Belinda Whitlock, a 55-year-old mother of four, initially attributed her fatigue, nausea, and stomach pain to the menopause. However, after a series of tests, she was diagnosed with advanced liver fibrosis, a condition caused by long-term inflammation linked to obesity. Belinda's mother died of liver cancer at 46, and the diagnosis hit her hard. She made drastic lifestyle changes, but her liver scans showed little improvement.
After reading about the potential impact of GLP-1 weight-loss drugs on liver disease, Belinda began paying for a private prescription. She lost five stone and her BMI dropped to 31. Remarkably, her liver fibrosis is reversing, and she feels hopeful for the future.
Professor Philip Newsome, a liver expert, says GLP-1 drugs could be key to tackling liver disease. The condition progresses through four stages, and while scarring can't be reversed, treating the underlying cause can lead to remarkable remodelling of scar tissue. This is life-changing for patients like Gillian Scott, who was diagnosed with cirrhosis after years of poorly controlled type 2 diabetes and obesity.
Gillian lost nine stone after her treatment was switched to Mounjaro, and her condition has improved from cirrhosis to fibrosis. A 2024 study found that 62% of patients taking the highest maintenance dose of Mounjaro saw their fatty liver disease resolve. However, GLP-1 drugs are not yet approved on the NHS for this condition, and the delay has come at a heavy cost for Belinda, who is still paying hundreds of pounds a month for the drug.
